Fertility and Sterility
Volume 84, Issue 1 , Pages 40-45, July 2005

Comparison of vaginal and oral administration of emergency contraception

  • Eliran Mor, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California
    • Corresponding Author InformationReprint requests: Eliran Mor, M.D., LAC+USC Medical Center, Department of Obstetrics and Gynecology, 1240 N. Mission Rd., Rm. 8K9, Los Angeles, California 90033 (FAX: 323-226-2850
  • ,
  • Peyman Saadat, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California
  • ,
  • Sari Kives, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Queen’s University, Kingston, Ontario, Canada
  • ,
  • Emily White, M.D.

      Affiliations

    • University of Adelaide, Adelaide, South Australia, Australia
  • ,
  • Robert L. Reid, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Queen’s University, Kingston, Ontario, Canada
  • ,
  • Richard J. Paulson, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California
  • ,
  • Frank Z. Stanczyk, Ph.D.

      Affiliations

    • Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California

Received 27 January 2004; received in revised form 24 January 2005; accepted 24 January 2005.

Objective

To compare the physiologic effects of vaginally and orally administered emergency contraception.

Design

Prospective, open-label, crossover study.

Setting

University research center.

Patient(s)

Nine regularly menstruating volunteers.

Intervention(s)

Five subjects received 1,000 μg of levonorgestrel with 200 μg of ethinyl E2 (twice the standard Yuzpe regimen dose) vaginally, and the standard Yuzpe regimen dose orally 1 week later. Four subjects received 1,500 μg of levonorgestrel (twice the standard Plan B regimen dose) vaginally and received the standard Plan B dose orally 1 week later. Serum samples were obtained at baseline and at frequent intervals after each dose.

Main Outcome Measure(s)

Serum gonadotropin, hepatic globulin, and androgen levels measured at baseline, at the time of peak levonorgestrel, and 24 hours later.

Result(s)

Gonadotropin, hepatic globulin, and androgen levels were suppressed to a similar degree among the four regimens, with a return to baseline levels after 24 hours.

Conclusion(s)

We conclude that high doses of levonorgestrel found in emergency contraception regimens lead to a transient direct suppression of gonadotropin, hepatic globulin, and androgen levels. This effect is similar after vaginal and oral administration of emergency contraception. Therefore, the vaginal route of administration of emergency contraception regimens may be as efficacious as the oral route.

Key Words:  Emergency contraception , vaginal administration , Yuzpe regimen , Plan B regimen , levonorgestrel , gonadotropins , androgens , hepatic globulins

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0015-0282(05)00588-1

doi:10.1016/j.fertnstert.2005.01.110

Fertility and Sterility
Volume 84, Issue 1 , Pages 40-45, July 2005